Compare ARK Genomic Revolution ETF (ARKG) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Mesoblast Limited — how do they compare? ARK Genomic Revolution ETF trades at $44.22, while Mesoblast Limited trades at $16.9 (market cap $2.21B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.
| ARKG | MESO | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $20.96 |
52-Week Low | $24.02 | $12.88 |
Market Cap | — | $2.21B |
Enterprise Value | — | $2.21B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
